SCHEMBL12528430

SCHEMBL12528430

Bc1ccc(O)c(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12667819 0.75 — —
SCHEMBL30800060 0.72 — —
SCHEMBL65710 0.72 — —
SCHEMBL20153036 0.72 CNR2 (0.39) —
SCHEMBL9967914 0.72 — —
SCHEMBL29377138 0.72 — —
SCHEMBL1686442 0.72 — —
SCHEMBL19880348 0.72 APP (0.55) —
SCHEMBL12951469 0.72 — —
SCHEMBL1755271 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012125926-A2 TETRACYCLIC XANTHENE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP (US) 2012-09-20 — — WO disclosed
Send feedback